Platelet glycoprotein IIb/IIIa receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease. [electronic resource]
Producer: 20030915Description: 536-41 p. digitalISSN:- 1524-4539
- Acetylcholine -- pharmacology
- Biological Availability
- Blood Flow Velocity -- drug effects
- Blood Platelets -- drug effects
- Coronary Artery Disease -- drug therapy
- Endothelium, Vascular -- drug effects
- Enzyme Inhibitors -- pharmacology
- Eptifibatide
- Forearm -- blood supply
- Humans
- Male
- Middle Aged
- Nitric Oxide -- metabolism
- Nitric Oxide Donors -- pharmacology
- Peptides -- pharmacology
- Platelet Aggregation Inhibitors -- pharmacology
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Plethysmography
- Tirofiban
- Tyrosine -- analogs & derivatives
- Vasodilation -- drug effects
- Vasodilator Agents -- pharmacology
- Vasomotor System -- drug effects
- omega-N-Methylarginine -- pharmacology
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.